Caribou Biosciences's total assets for Q3 2025 were $194.98M, a decrease of -11.73% from the previous quarter. CRBU total liabilities were $53.14M for the fiscal quarter, a -2.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.